Diabetes complications

Global, regional and national burdens of chronic kidney disease due to T1DM and T2DM among adolescents and young adults aged 10–35 years from 1990–2021: A trend analysis based on the global burden of disease study 2021

Diabetes Res Clin PractPublished Trend analysis of Global Burden of Disease 2021 data

Authors' conclusion

The burden of CKD-T1D and CKD-T2D showed a pandemic-related shift. Middle-SDI countries face high incidence and mortality, while high-SDI countries report lower mortality but higher prevalence. Public health interventions are especially needed in low and middle-SDI countries and island nations.

Study context

Population
Adolescents and young adults aged 10–35 years with chronic kidney disease (CKD) due to T1D (CKD-T1D) or T2D (CKD-T2D), global, regional and national levels, 1990–2021
Outcome
Trends in CKD-T1D and CKD-T2D incidence, prevalence, mortality and DALYs
Follow-up
1990–2021
Methodological detailsjoinpoint regression analysis, decomposition analysis
  • Joinpoint regression analysis
  • Decomposition analysis

Main finding

As reported in the abstract

  • Globally, CKD-T1D incidence rose until 2019, then declined
  • CKD-T2D incidence declined initially, then increased after 2019
  • Males generally had higher values of all indicators, except CKD-T1D prevalence, higher in females
  • Central Latin America had the largest mortality increase; Oceania had the highest mortality rates
  • Oceania countries had the highest disability-adjusted life years (DALYs) for both CKD types in 2021

Original publication

Global, regional and national burdens of chronic kidney disease due to T1DM and T2DM among adolescents and young adults aged 10–35 years from 1990–2021: A trend analysis based on the global burden of disease study 2021. Diabetes Res Clin Pract. Published 3 January 2025. doi:10.1016/j.diabres.2024.111985

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.